New Relapse Model in Psychiatry

NCT ID: NCT06244641

Last Updated: 2024-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-12

Study Completion Date

2028-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn about risk factors of relapse in patients with alcohol use disorder. The main questions it aims to answer are :

* Among patients with Alcohol Use Disorder, are there clusters of patients with the same characteristics and the same outcome ?
* Which are the risk factors of relapse that are the most predictive ? Do they vary according to cluster?
* Can a feedback-measurment-system (eg : a feedback of the tests' results) be usefull in a detoxification unit ?

Participants will :

* Complete auto-questionnaires
* Pass hetero-evaluations
* Undergo an electrophysiological battery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol Use Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

clustering relapse feedback-measurment-system

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Group Type EXPERIMENTAL

Auto-questionnaires, hetero-questionnaires and Evoked-potentials

Intervention Type OTHER

Evaluations of risk factors of relapse by questionnaires, evaluation of evoked-potentials

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Auto-questionnaires, hetero-questionnaires and Evoked-potentials

Evaluations of risk factors of relapse by questionnaires, evaluation of evoked-potentials

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To suffer from AUD
* To be hospitalized
* To speak French fluently
* To be able to give their consent (medically and legally).

Exclusion Criteria

* To suffer from severe perceptive disabilities (auditory, visual)
* To suffer from severe cognitive impairment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fonds National de la Recherche Scientifique

OTHER

Sponsor Role collaborator

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe de Timary, PhD

Role: PRINCIPAL_INVESTIGATOR

Université catholique de Louvain (Wallonia)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires Saint-Luc

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Claire Emmanuèle Marie Ledouble

Role: CONTACT

Phone: +32474731113

Email: [email protected]

Philippe de Timary, PhD

Role: CONTACT

Phone: +3227642160

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Claire Ledouble

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/09MAI/22

Identifier Type: -

Identifier Source: org_study_id